Platelet-albumin-bilirubin score and systemic immune-inflammation index for assessing the prognosis of acute ischemic stroke patients

Selcen Duran, Asuman Celikbilek, Aysu Yetis, Burc Esra Sahin, Aydan Koysuren, Memis Bolacalı, Bekircan Polat

DOI: 10.55697/tnd.2025.232

Issue: 2025, Volume 31 - Issue 1
1986 1409

The effect of demographic features and environmental risk factors on the clinical course in patients with multiple sclerosis

İrem İlgezdi Kaya, Bedile İrem Tiftikçioğlu, Yaşar Zorlu, Levent Öcek, Ufuk Şener, Figen Tokuçoğlu

DOI: 10.55697/tnd.2025.211

Issue: 2025, Volume 31 - Issue 2
1638 1224

The effect of dual-tasking on functional mobility and manual dexterity in people with multiple sclerosis at different stages of disability

Çağrı Gülşen, Fatma Aydın, Fatih Söke, Bilge Koçer, Elvan Özcan Gülşen, Öznur Yilmaz, Selim Selçuk Çomoğlu

DOI: 10.55697/tnd.2025.265

Issue: 2025, Volume 31 - Issue 2
2018 1635

Cognitive functions in radiologically isolated syndrome

Pelin Soydar, Hatice Mavioğlu

DOI: 10.55697/tnd.2025.262

Issue: 2025, Volume 31 - Issue 2
1933 1035

Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19

Nazire Pınar Acar Ozen, Dilara Cilizoglu, Bernanur Toprak, Nartan Demirok, Yeliz Salci, Rana Karabudak, Umut Beşpinar, Aslı Tuncer

DOI: 10.55697/tnd.2025.347

Issue: 2025, Volume 31 - Issue 2
1348 1022

Alemtuzumab-induced antineutrophil cytoplasmic antibody-associated nephritis in a patient with multiple sclerosis

Furkan Sarıdaş, Saide Elif Güllülü Boz, Belkıs Nihan Coşkun, Emine Rabia Koç, Abdulmecit Yıldız, Berna Aytaç Vuruşkan, Ömer Faruk Turan

DOI: 10.55697/tnd.2024.238

Issue: 2025, Volume 31 - Issue 2
1237 1039

Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

Hazal Ceren Manazoğlu, Murat Kürtüncü

DOI: 10.55697/tnd.2025.500

Issue: 2025, Volume 31 - Issue 3
15938 10133

Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study

Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2025.494

Issue: 2025, Volume 31 - Issue 3
1988 1360

The relationship of pain, disability, and kinesiophobia levels with heart rate variability in patients with migraine: A prospective cross-sectional study

Rabia Tuğba Tekin, Hilal Aslan, Şadiye Gümüşyayla

DOI: 10.55697/tnd.2025.341

Issue: 2025, Volume 31 - Issue 3
1710 1115

Long-term cladribine experience in relapsing-remitting multiple sclerosis

Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç

DOI: 10.55697/tnd.2025.293

Issue: 2025, Volume 31 - Issue 3
1432 1264

Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis

Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi

DOI: 10.55697/tnd.2025.323

Issue: 2025, Volume 31 - Issue 4
847 816

Audiovestibular findings according to the subtypes of multiple sclerosis

Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz

DOI: 10.55697/tnd.2025.442

Issue: 2025, Volume 31 - Issue 4
700 898

Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning

Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş

DOI: 10.55697/tnd.2025.511

Issue: 2025, Volume 31 - Issue 4
931 872

The effect of fingolimod on complete blood count, lipid panel, and relationship with clinicoradiologic features in patients with multiple sclerosis

Furkan Sarıdaş, Sarah Hamide Lazrak, Emine Rabia Koç, Güven Özkaya, Ömer Faruk Turan

DOI: 10.55697/tnd.2025.213

Issue: 2025, Volume 31 - Issue 4
797 635

Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis

Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci

DOI: 10.55697/tnd.2026.622

Issue: 2026, Volume 32 - Issue 1
270 243